Page 1 of Clinical Trials for Procedure syngeneic bone marrow transplantation, 19 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Recruiting
Carmustine, Etoposide, Cytarabine, Melphalan, and Antithymocyte Globulin Followed by Peripheral Blood Stem Cell Transplant in Treating Patients With Autoimmune Neurologic Disease That Did Not Respond to Previous Therapy
Last Updated: January 30, 2012
Condition(s): Autoimmune Disorder
2
Recruiting
Autologous or Syngeneic Stem Cell Transplant Followed by Donor Stem Cell Transplant and Bortezomib in Treating Patients With Newly Diagnosed High-Risk, Relapsed, or Refractory Multiple Myeloma
Last Updated: January 9, 2012
Condition(s): Refractory Multiple Myeloma; Stage I Multiple Myeloma; Stage II Multiple Myeloma; Stage III Multiple Myeloma
3
Completed
Chemotherapy Plus Bone Marrow Transplantation in Treating Patients With Refractory Non-Hodgkin's Lymphoma, Hodgkin's Disease, or Multiple Myeloma
Last Updated: April 13, 2010
Condition(s): Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm
4
Completed
Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
Last Updated: September 30, 2010
Condition(s): Lymphoma
5
Completed
Combination Chemotherapy and Bone Marrow and/or Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma
Last Updated: September 30, 2010
Condition(s): Lymphoma
6
Completed
Chemotherapy and Bone Marrow Transplantation in Treating Patients Acute Myeloid With Leukemia or Myelodysplastic Syndrome
Last Updated: April 13, 2010
Condition(s): Leukemia; Myelodysplastic Syndromes
7
Active, not recruiting
Combination Chemotherapy Followed by Donor Bone Marrow Transplant or Peripheral Stem Cell Transplant in Treating Patients With Hematologic Cancer or Genetic Disorders
Last Updated: June 4, 2011
Condition(s): Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes
8
Completed
Multiple Therapies in Treating Patients With Advanced Neuroblastoma
Last Updated: December 13, 2009
Condition(s): Neuroblastoma
9
Completed
An Open Trial Combining Zidovudine, Interferon-alfa, and Recombinant CD4-IgG With Transplantation of Syngeneic Bone Marrow and Peripheral Blood Lymphocytes From Healthy gp160-Immunized Donors in the Treatment of Patients With HIV Infection
Last Updated: May 17, 2012
Condition(s): HIV Infections
10
Completed
Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma
Last Updated: June 21, 2011
Condition(s): Multiple Myeloma and Plasma Cell Neoplasm
11
Active, not recruiting
LMP2a-Specific Cytotoxic T-Lymphocytes Following CD45 Antibody for Lymphoma
Last Updated: April 13, 2012
Condition(s): Lymphoma
12
Recruiting
Busulfan, Fludarabine, and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Stem Cell Transplant for Hematologic Cancer
Last Updated: March 20, 2012
Condition(s): Chronic Myeloproliferative Disorders; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Neoplasms; Precancerous Condition
13
Recruiting
Melphalan and Amifostine Followed By One or Two Autologous or Syngeneic Stem Cell Transplants and Maintenance Therapy in Treating Patients With Stage II-III Multiple Myeloma
Last Updated: December 28, 2011
Condition(s): Refractory Multiple Myeloma; Stage II Multiple Myeloma; Stage III Multiple Myeloma
14
Completed
Stem Cell Transplantation in Patients With High-Risk and Recurrent Pediatric Sarcomas
Last Updated: April 14, 2012
Condition(s): Sarcoma
15
Not yet recruiting
Rapidly Generated LMP, BARF1 and EBNA1 Specific Cytotoxic T-Lymphocytes
Last Updated: March 15, 2012
Condition(s): Epstein-Barr Virus-Related Lymphoma; Hodgkin's Lymphoma; Non-Hodgkin's Lymphoma; Lymphoma, Extranodal NK-T-Cell
16
Withdrawn
Lenalidomide With or Without Rituximab in Treating Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Who Have Undergone Autologous or Syngeneic Stem Cell Transplant
Last Updated: July 1, 2011
Condition(s): Leukemia; Lymphoma
17
Recruiting
Safety Study of Injections of Autologous/Allogeneic TGFbeta-resistant LMP2A-specific Cytotoxic T-lymphocytes (CTL)
Last Updated: April 13, 2012
Condition(s): Lymphoma
18
Completed
Chemotherapy Followed by Peripheral Stem Cell Transplantation And Biological Therapy in Treating Patients With Chronic Myelogenous Leukemia
Last Updated: March 31, 2010
Condition(s): Leukemia
19
Recruiting
LMP-specific T-cells for Patients With Relapsed EBV-positive Lymphoma
Last Updated: April 13, 2012
Condition(s): Hodgkin Disease; Non Hodgkin Lymphoma

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=Procedure+syngeneic+bone+marrow+transplantation

Page 1 of Clinical Trials for Procedure syngeneic bone marrow transplantation, 19 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About